Fluoxetine-induced change in rat brain expression of brain-derived neurotrophic factor varies depending on length of treatment

Neuroscience

Volumn 128, Issue 3, 2004, Pages 597-604

  De Foubert, G ^a   Carney, S L ^b   Robinson, C S ^b   Destexhe, E J ^c   Tomlinson, R ^b   Hicks, C A ^b   Murray, T K ^b   Gaillard, J P ^c   Deville, C ^c   Xhenseval, V ^c   Thomas, C E ^c   O'Neill, M J ^b   Zetterstrom T S C ^a  

^a DE MONTFORT UNIVERSITY   (United Kingdom)

^b ELI LILLY AND COMPANY   (United States)

^c Eli Lilly Benelux   (Belgium)

Author keywords

5 HT; antidepressants; Arc; BDNF; gene expression; protein expression

Indexed keywords

ANTIDEPRESSANT AGENT; BRAIN DERIVED NEUROTROPHIC FACTOR; BRAIN PROTEIN; FLUOXETINE; MESSENGER RNA; SEROTONIN UPTAKE INHIBITOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN LEVEL; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION; HABENULA; HIPPOCAMPUS; HISTOCHEMISTRY; IMMUNOCYTOCHEMISTRY; IMMUNOREACTIVITY; IN SITU HYBRIDIZATION; MALE; NEUROMODULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PYRAMIDAL NERVE CELL; RAT; STATISTICAL SIGNIFICANCE; THALAMUS MIDLINE NUCLEUS; UPREGULATION;

ANIMALS; BRAIN; BRAIN-DERIVED NEUROTROPHIC FACTOR; CYTOSKELETAL PROTEINS; DEPRESSIVE DISORDER; DOWN-REGULATION; DRUG ADMINISTRATION SCHEDULE; FLUOXETINE; HIPPOCAMPUS; MALE; NERVE TISSUE PROTEINS; PYRAMIDAL CELLS; RATS; RATS, SPRAGUE-DAWLEY; REACTION TIME; RNA, MESSENGER; SEROTONIN UPTAKE INHIBITORS; TIME FACTORS;

EID: 4644271811     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2004.06.054     Document Type: Article

References (40)

1. C.A. Altar, R.E. Whitehead, R. Chen, G. Wortwein, T.M. Madsen Effects of electroconvulsive seizures and antidepressant drugs on brain-derived neurotrophic factor protein in rat brain Biol Psychiatry 54 2003 703 709
2. K. Ainsworth, S.E. Smith, T.S.C. Zetterström, Q. Pei, M. Franklin, T. Sharp Effect of antidepressant drugs on dopamine D1 and D2 receptor expression and dopamine release in the nucleus accumbens of the rat Psychopharmacology 140 1998 470 477
3. K.H. Andres, M. von During, R.W. Veh Subnuclear organization of the rat habenular complexes J Comp Neurol 407 1999 130 150
4. S. Bhatnagar, R. Huber, N. Nowak, P. Trotter Lesions of the posterior paraventricular thalamus block habituation of hypothalamic-pituitary-adrenal responses to repeated restraint J Neuroendocrin 14 2002 403 410
5. 4 receptor activation Naunyn Schmiedebergs Arch Pharmacol 363 2001 491 498
6. P. Blier, C. Montigny, Y. Chaput Modifications of the serotonin system by antidepressant treatments: implications for the therapeutic response in major depression J Clin Psychopharmacol 7 6 Suppl 1987 24S 35S
7. B. Chen, D. Dowlatshahi, G.M. MacQueen, J.F. Wang, L.T. Young Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication Biol Psychiatry 50 2001 260 265
8. J.M. Conner, J.C. Lauterborn, Q. Yan, C.M. Gall, S. Varon Distribution of brain-derived neurotrophic factor (BDNF) protein and mRNA in the normal adult rat CNS: evidence for anterograde axonal transport J Neurosci 17 1997 2295 2313
9. A.C. Conti, J.F. Cryan, A. Dalvi, I. Lucki, J.A. Blendy cAMP response element-binding protein is essential for the upregulation of brain-derived neurotrophic factor transcription, but not the behavioural or endocrine responses to antidepressant drugs J Neurosci 22 2002 3262 3268
10. 4 receptor-mediated regulation of BDNF mRNA by fluoxetine in the hippocampus Eur J Neurosci 12 Suppl. 11 2000 17
11. A.L. Coppell, Q. Pei, T.S.C. Zetterström Bi-phasic change in BDNF gene expression following antidepressant drug treatment Neuropharmacology 44 2003 903 910
12. R.S. Duman, G.R. Heninger, E.J. Nestler A molecular and cellular theory of depression Arch Gen Psychiatry 54 1997 597 606
13. R.S. Duman Novel therapeutic approaches beyond the serotonin receptor Biol Psychiatry 44 1998 324 335
14. J.M. Elliott, S.L. Phipps, Q. Pei, T.S.C. Zetterström, D.G. Grahame-Smith Electroconvulsive shock induces localised and persistent increases in BDNF protein in rat brain Br J Pharmacol 126 Suppl 1999 5
15. 1A receptor antagonist and an SSRI in vivo: effects on 5-HT cell firing and extracellular 5-HT Br J Pharmacol 115 1995 1064 1070
16. F. Karege, G. Perret, G. Bondolfi, M. Schwald, G. Bertschy, J.M. Aubry Decreased serum brain-derived neurotrophic factor levels in major depressed patients Psychiatry Res 109 2002 143 148
17. A.A. Khundakar, T.S.C. Zetterström Differential expression of BDNF exons in rat brain after systemic administration of paroxetine and tranylcypromine Br J Pharmacol 137 Suppl 2002 57
18. J.C. Lauterborn, S. Rivera, C.T. Stinis, V.Y. Hayes, P.J. Isackson, C.M. Gall Differential effects of protein synthesis inhibition on the activity dependent expression of BDNF transcripts: evidence for immediate-early gene responses from specific promoters J Neurosci 16 1996 7428 7436
19. M. Mackowiak, M.J. O'Neill, C.A. Hicks, D. Bleakman, P. Skolnick An AMPA receptor potentiator modulates the expression of BDNF: an in vivo study Neuropharmacology 43 2002 1 10
20. S.N. Mitchell, R.G. Greenslade, J. Cooper LY393558, a 5-hydroxytryptamine uptake inhibitor and 5-HT1B/1D receptor antagonists: effects on extracellular levels of 5-hydroxytryptamine in the guinea pig and rat Eur J Pharmacol 432 2001 19 27
21. E.J. Nestler, M. Barrot, R.J. DiLeone, A.J. Eisch, S.J. Gold, L.M. Monteggia Neurobiology of depression Neuron 34 2002 13 25
22. M. Nibuya, S. Morinobu, R.S. Duman Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments J Neurosci 15 1995 7539 7547
23. M. Nibuya, E.J. Nestler, R.S. Duman Chronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus J Neurosci 16 1996 2365 2372
24. O'Neill MJ, Clemens JA (2000) Rodent models of global cerebral ischemia. In: Current protocols in neuroscience (Crawley J, Gerfen C, McKay R, Sibley D, Rogowski M, Skolnick P, eds), pp 1-25. New York: John Wiley.
25. Q. Pei, P.W. Burnet, D.G. Grahame-Smith, T.S.C. Zetterström Differential effects of acute and chronic electroconvulsive shock on the abundance of messenger RNAs for voltage-dependent potassium channel subunits in the rat brain Neuroscience 78 1997 343 350
26. Q. Pei, L. Lewis, M.E. Sprakes, E.J. Jones, D.G. Grahame-Smith, T.S.C. Zetterström Serotonergic regulation of mRNA expression of Arc, an immediate early gene selectively localised at neuronal dendrites Neuopharmacology 39 2000 463 470
27. Q. Pei, T.S.C. Zetterström, M.E. Sprakes, R. Tordera, T. Sharp Antidepressant drug treatment induces Arc gene expression in the rat brain Neuroscience 121 2003 975 982
28. K. Ranft, H. Bernstein, S.S. Diekmann, D. Krell, P. Danos, B. Baumann, B. Bogerts Evidence for structural abnormalities of the habenular complex in affective disorder but not in schizophrenia Soc Neurosci Abstr 640 2003 17P
29. A.A. Russo-Neustadt, R.C. Beard, Y.M. Huang, C.W. Cotman Physical activity and antidepressant treatment potentiate the expression of specific brain-derived neurotrophic factor transcripts in the rat hippocampus Neuroscience 101 2000 305 312
30. A. Russo-Neustadt Brain-derived neurotrophic factor, behaviour, and new directions for the treatment of mental disorders Semin Clin Neuropsychiatry 8 2003 109 118
31. M.A. Smith, L. Zhang, W.E. Lyons, L.A. Mamounas Anterograde transport of endogenous brain-derived neurotrophic factor in hippocampal mossy fibers Neuroreport 8 1997 1829 1834
32. E. Shimizu, K. Hashimoto, N. Okamura, K. Koike, N. Komatsu, C. Kumakiri, M. Nakazato, H. Watanabe, N. Shinoda, S. Okada, M. Iyo Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants Biol Psychiatry 54 2003 70 75
33. Y. Shirayama, A.C. Chen, S. Nakagawa, D.S. Russell, R.S. Duman Brain-derived neurotrophic factor produces antidepressant effects in behavioural models of depression J Neurosci 22 2002 3251 3261
34. J.A. Siuciak, D.R. Lewis, S.J. Weigand, R. Lindsay Antidepressant-like effect of brain derived neurotrophic factor (BDNF) Pharmacol Biochem Behav 56 1997 131 137
35. 2+ influx regulates BDNF transcription by a CREB family transcription factor-dependent mechanism Neuron 20 1998 709 726
36. T. Timmusk, K. Palm, M. Metsis, T. Reintam, V. Paalme, M. Saarma, H. Persson Multiple promoters direct tissue-specific expression of the rat BDNF gene Neuron 10 1993 475 489
37. 2+ and cAMP requires protein kinase A and mitogen-activated protein kinase/extracellular regulated kinase activation J Neurosci 21 2001 5484 5493
38. H. Xu, J.S. Richardson, X.-M. Li Dose-related effects of chronic antidepressants on neuroprotective proteins BDNF, Bcl-2 and Cu/Zn-SOD in rat hippocampus Neuropsychopharmacology 28 2003 53 62
39. S.W. Ying, M. Futter, K. Rosenblum, M.J. Webber, S.P. Hunt, T.V. Bliss, C.R. Bramham Brain-derived neurotrophic factor induces long-term potentiation in intact adult hippocampus: requirement for ERK activation coupled to CREB and upregulation of Arc synthesis J Neurosci 22 2002 1532 1540
40. T.S.C. Zetterström, Q. Pei, T.R. Madhav, A.L. Coppell, D.G. Grahame-Smith Manipulations of brain 5-HT levels affect gene expression for BDNF in rat brain Neuropharmacology 38 1999 1063 1073